Menu
Your Cart

Magnetic Nanoparticles

Magnetic Nanoparticles
Apostle MiniMax technology ensures precise capture and separation of DNA, RNA, and other biomolecules. This is achieved through Apostle’s novel proprietary MiniMax magnetic nanoparticles with innovative features:Novel material composition and surface chemistry - completely distinct from the conventi..
$864.00
Apostle MiniMax technology ensures precise capture and separation of DNA, RNA, and other biomolecules. This is achieved through Apostle’s novel proprietary MiniMax magnetic nanoparticles with innovative features:Novel material composition and surface chemistry - completely distinct from the conventi..
$3,434.40
Showing 1 to 2 of 2 (1 Pages)
A new clinical study, led by scientists from MD Anderson Cancer Center and published in Cancer Cell (journal impact factor = 50.3), shows that tumor and cfDNA methylation can be used to identify SCLC subtypes and might guide precision SCLC therapy. Apostle MiniMax cfDNA kit is one of the critical commercial assays listed in this article. Congratulations to this clinical research team. To date, the Apostle MiniMax technology has been used in 2 articles published in Nature Communications, 2 in Nature Medicine, 1 in Science Translational Medicine, 1 in PNAS, and over 60 scientific articles by over 60 international research and clinical teams in different journals.